MediPharm Labs Corp.
LABS.TO
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.06% | -27.30% | -16.98% | -17.37% | -5.17% |
Total Receivables | 8.39% | 3.85% | 5.38% | 9.02% | -4.72% |
Inventory | -7.69% | 21.84% | -11.11% | -3.38% | -3.11% |
Prepaid Expenses | 342.45% | -58.67% | -40.57% | -21.35% | 264.87% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -78.12% | 1.80% | -6.52% | -2.00% | 296.81% |
Total Current Assets | -2.19% | -3.77% | -10.14% | -7.65% | 7.89% |
|
|||||
Total Current Assets | -2.19% | -3.77% | -10.14% | -7.65% | 7.89% |
Net Property, Plant & Equipment | 3.53% | -1.66% | -8.37% | -0.91% | -18.93% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -0.46% | -5.17% | -10.71% | -3.53% | -5.47% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -10.55% | 0.11% | -20.30% | -16.26% | -9.10% |
Total Assets | -0.20% | -2.99% | -9.66% | -5.46% | -3.33% |
|
|||||
Total Accounts Payable | -0.56% | 15.53% | 13.40% | 34.11% | -27.55% |
Total Accrued Expenses | 37.74% | -51.60% | -17.92% | -4.51% | 38.29% |
Short-term Debt | 3,301.03% | -94.59% | -57.58% | -78.66% | 35.67% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 7.90% | 1.46% | 54.65% | -6.58% | -35.70% |
Total Finance Division Other Current Liabilities | -4.25% | 15.26% | -10.25% | 14.70% | -25.53% |
Total Other Current Liabilities | -4.25% | 15.26% | -10.25% | 14.70% | -25.53% |
Total Current Liabilities | 13.49% | -16.03% | -8.42% | -10.53% | 6.38% |
|
|||||
Total Current Liabilities | 13.49% | -16.03% | -8.42% | -10.53% | 6.38% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 3,301.03% | -94.59% | -57.58% | -78.66% | 35.67% |
Capital Leases | -66.20% | -38.98% | 36.68% | -24.49% | -19.86% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 13.21% | -16.14% | -8.27% | -10.58% | 6.24% |
|
|||||
Common Stock & APIC | 5.61% | 0.11% | -5.99% | 1.31% | -0.80% |
Retained Earnings | -4.64% | -0.31% | 5.24% | -2.85% | -0.36% |
Treasury Stock & Other | -12.85% | 1.56% | -7.36% | 2.02% | -1.68% |
Total Common Equity | -2.94% | 0.21% | -10.00% | -4.14% | -5.52% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.94% | 0.21% | -10.00% | -4.14% | -5.52% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.94% | 0.21% | -10.00% | -4.14% | -5.52% |
|